Impact of somatic mutations on response to lenalidomide in lower-risk non-del(5q) myelodysplastic syndromes patients

Journal Name
Leukemia
Primary Author
Santini, V
Author(s)
Valeria Santini, Pierre Fenaux, Aristoteles Giagounidis, Uwe Platzbecker, Alan F List, Torsten Haferlach, Jim Zhong, Chengqing Wu, Konstantinos Mavrommatis, C L Beach, Kyle J MacBeth, Antonio Almeida
Original Publication Date
Full Article on PubMed
https://www.ncbi.nlm.nih.gov/pubmed/32661294
Diseases
Myelodysplastic Syndromes (MDS)

Website Feedback

Please use this feedback form to report website issues only. For other issues concerning patients and families, please email help@aamds.org or use the Patient and Family Helpline here.

We Recommend

For Research